The Valley Desk

NCT02513550 · Interventional trial

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

Overall registry status Completed

Phase 3

Conditions Plaque Psoriasis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov